Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 277

1.

[Clinical pharmacological aspects of new oral anticoagulants].

Haschke M.

Ther Umsch. 2012 Nov;69(11):657-60. doi: 10.1024/0040-5930/a000344. Review. German.

PMID:
23117669
[PubMed - indexed for MEDLINE]
2.

The laboratory and the new oral anticoagulants.

Tripodi A.

Clin Chem. 2013 Feb;59(2):353-62. doi: 10.1373/clinchem.2012.189704. Epub 2012 Oct 5. Review.

PMID:
23043068
[PubMed - indexed for MEDLINE]
Free Article
3.

Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.

Gong IY, Kim RB.

Can J Cardiol. 2013 Jul;29(7 Suppl):S24-33. doi: 10.1016/j.cjca.2013.04.002. Review.

PMID:
23790595
[PubMed - indexed for MEDLINE]
4.

The new oral anticoagulants in clinical practice.

Gonsalves WI, Pruthi RK, Patnaik MM.

Mayo Clin Proc. 2013 May;88(5):495-511. doi: 10.1016/j.mayocp.2013.03.006. Review. Erratum in: Mayo Clin Proc. 2013 Jul;88(7):777.

PMID:
23639500
[PubMed - indexed for MEDLINE]
5.

[Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests].

Nagler M, Wuillemin W.

Ther Umsch. 2012 Nov;69(11):650-6. doi: 10.1024/0040-5930/a000343. Review. German.

PMID:
23117668
[PubMed - indexed for MEDLINE]
6.

New oral anticoagulants: will they replace warfarin?

Little JW.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 May;113(5):575-80. doi: 10.1016/j.oooo.2011.10.006. Epub 2012 Mar 3. Review.

PMID:
22668618
[PubMed - indexed for MEDLINE]
7.

Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban.

Fawole A, Daw HA, Crowther MA.

Cleve Clin J Med. 2013 Jul;80(7):443-51. doi: 10.3949/ccjm.80a.13025. Review.

PMID:
23821689
[PubMed - indexed for MEDLINE]
Free Article
8.

Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.

Graff J, Harder S.

Clin Pharmacokinet. 2013 Apr;52(4):243-54. doi: 10.1007/s40262-013-0034-0. Review.

PMID:
23389892
[PubMed - indexed for MEDLINE]
9.

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.

Steiner T, Böhm M, Dichgans M, Diener HC, Ell C, Endres M, Epple C, Grond M, Laufs U, Nickenig G, Riess H, Röther J, Schellinger PD, Spannagl M, Veltkamp R.

Clin Res Cardiol. 2013 Jun;102(6):399-412. doi: 10.1007/s00392-013-0560-7. Epub 2013 May 14. Review.

PMID:
23669868
[PubMed - indexed for MEDLINE]
10.

[The new Anticoagulants - Relevant Facts for the GP].

Asmis LM.

Praxis (Bern 1994). 2011 Aug 10;100(16):971-6. doi: 10.1024/1661-8157/a000627. Review. German.

PMID:
21833915
[PubMed - indexed for MEDLINE]
11.

Bleeding and antidotes in new oral anticoagulants.

Majeed A, Schulman S.

Best Pract Res Clin Haematol. 2013 Jun;26(2):191-202. doi: 10.1016/j.beha.2013.07.001. Epub 2013 Jul 21. Review.

PMID:
23953907
[PubMed - indexed for MEDLINE]
12.

Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.

[No authors listed]

Prescrire Int. 2013 Jun;22(139):155-9. Review.

PMID:
23866358
[PubMed - indexed for MEDLINE]
13.

Novel oral anticoagulants--key messages for the angiologist.

Haas S, Spannagl M, Schellong SM.

Vasa. 2012 May;41(3):177-91. doi: 10.1024/0301-1526/a000184. Review.

PMID:
22565619
[PubMed - indexed for MEDLINE]
14.

The new oral anticoagulants: a challenge for hospital formularies.

Merli GJ.

Hosp Pract (1995). 2012 Aug;40(3):126-8. doi: 10.3810/hp.2012.08.996.

PMID:
23086101
[PubMed - indexed for MEDLINE]
15.

A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.

Kasmeridis C, Lip GY, Apostolakis S.

Hosp Pract (1995). 2013 Feb;41(1):61-70. doi: 10.3810/hp.2013.02.1011. Review.

PMID:
23466968
[PubMed - indexed for MEDLINE]
16.

[General characteristics of the new oral anticoagulants].

Gegu M, Chevalet P, Piloquet FX, Berrut G, De Decker L.

Geriatr Psychol Neuropsychiatr Vieil. 2013 Dec;11(1 Suppl):4-9. doi: 10.1684/pnv.2013.0446. Review. French.

PMID:
24463058
[PubMed - indexed for MEDLINE]
17.

Acute management of bleeding in patients on novel oral anticoagulants.

Siegal DM, Crowther MA.

Eur Heart J. 2013 Feb;34(7):489-498b. doi: 10.1093/eurheartj/ehs408. Epub 2012 Dec 7. Review.

PMID:
23220847
[PubMed - indexed for MEDLINE]
Free Article
18.

Drug and dietary interactions of the new and emerging oral anticoagulants.

Walenga JM, Adiguzel C.

Int J Clin Pract. 2010 Jun;64(7):956-67. doi: 10.1111/j.1742-1241.2009.02286.x. Review.

PMID:
20584229
[PubMed - indexed for MEDLINE]
19.

Perioperative management of patients on new oral anticoagulants.

Lai A, Davidson N, Galloway SW, Thachil J.

Br J Surg. 2014 Jun;101(7):742-9. doi: 10.1002/bjs.9485. Epub 2014 Apr 29.

PMID:
24777590
[PubMed - indexed for MEDLINE]
20.

What did we learn from new oral anticoagulant treatment?

Esmon CT.

Thromb Res. 2012 Oct;130 Suppl 1:S41-3. doi: 10.1016/j.thromres.2012.08.271. Review.

PMID:
23026659
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk